Haemonetics (FRA:HAZ) EV-to-Revenue : 4.16 (As of May. 21, 2024)

View and export this data going back to . Start your Free Trial

What is Haemonetics EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Haemonetics's enterprise value is €5,028 Mil. Haemonetics's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €1,210 Mil. Therefore, Haemonetics's EV-to-Revenue for today is 4.16.

The historical rank and industry rank for Haemonetics's EV-to-Revenue or its related term are showing as below:

FRA:HAZ' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.78 Med: 3.83 Max: 8.23
Current: 4.18

During the past 13 years, the highest EV-to-Revenue of Haemonetics was 8.23. The lowest was 1.78. And the median was 3.83.

FRA:HAZ's EV-to-Revenue is ranked worse than
59.64% of 830 companies
in the Medical Devices & Instruments industry
Industry Median: 3.265 vs FRA:HAZ: 4.18

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-21), Haemonetics's stock price is €89.50. Haemonetics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €23.54. Therefore, Haemonetics's PS Ratio for today is 3.80.

Haemonetics EV-to-Revenue Historical Data

The historical data trend for Haemonetics's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haemonetics EV-to-Revenue Chart

Haemonetics Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EV-to-Revenue

Get a 7-Day Free Trial

5.38

7.09

3.77

3.98

3.79

Haemonetics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															3.98	3.94	4.00	3.95	3.79

Competitive Comparison of Haemonetics's EV-to-Revenue

For the Medical Instruments & Supplies subindustry, Haemonetics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Haemonetics's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Haemonetics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Haemonetics's EV-to-Revenue falls into.

Haemonetics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Haemonetics's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	5028.404	/	1209.664
	=	4.16

Haemonetics's current Enterprise Value is €5,028 Mil.
Haemonetics's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,210 Mil.

Haemonetics (FRA:HAZ) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Haemonetics's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	89.50	/	23.536
	=	3.80

Haemonetics's share price for today is €89.50.
Haemonetics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €23.54.

Haemonetics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Haemonetics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Haemonetics (FRA:HAZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Haemonetics Corp (FRA:HAZ) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

HAE:USA HAZ:Germany

Address

125 Summer Street, Boston, MA, USA, 02110

Website

https://www.haemonetics.com

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Haemonetics (FRA:HAZ) Headlines

No Headlines